Hepatitis C - 2/19

Entry	Author	Date	Location
Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug	Luke Timmerman	05/23/11	Boston
Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry	Luke Timmerman	05/17/11	New York
Merck Wins Approval for HCV Drug	Arlene Weintraub	05/13/11	New York
Vertex Signs Boston Lease	Luke Timmerman	05/05/11	Boston
New Health IT Startup Targets Military Programs, Allylix Sniffs New Market for Nootkatone, Biocept Builds Team, & More San Diego Life Sciences News	Bruce V. Bigelow	05/05/11	San Diego
FDA Panel OKs Vertex Drug, Dyax Works With FivePrime, Genzyme Amends Anika Lawsuit, & More Boston-Area Life Sciences News	Erin Kutz	04/29/11	Boston
Vertex Wins FDA Panel’s Recommendation for New Hepatitis C Drug	Luke Timmerman	04/28/11	Boston
FDA Panel Meets Today on Vertex HepC Drug	Ryan McBride	04/28/11	Boston
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	04/28/11	San Diego
FDA Says Vertex Drug a Wee Bit More Effective Than Advertised; Stock Climbs	Luke Timmerman	04/26/11	Boston
Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week	Luke Timmerman	04/25/11	Boston
Novartis, Trying Not to Burn the Hamburger, Increases its Bet on the Bay Area	Luke Timmerman	04/19/11	San Francisco
Zacharon Aligns with Pfizer, Conatus Raises Big Bucks, Software Veteran Wins Wireless Institute Challenge, & More San Diego Life Sciences News	Bruce V. Bigelow	04/14/11	San Diego
Conatus Adds $7.5M, Closes Series B Round	Bruce V. Bigelow	04/13/11	San Diego
ITherX Repurposes Kemia Drug	Bruce V. Bigelow	03/24/11	San Diego
Date Set for Key Meeting on Vertex Drug	Ryan McBride	03/18/11	Boston
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised	Luke Timmerman	03/14/11	National
Vertex Stock Up 15 Percent on CF Data	Ryan McBride	02/23/11	Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug	Luke Timmerman	02/23/11	Boston
Quanterix, Novartis Test Out Super-Sensitive Diagnostic Tool for Neuro Disorder	Luke Timmerman	02/22/11	Boston
Conatus Raises $20M for Hepatitis C Studies	Bruce V. Bigelow	02/14/11	San Diego
FDA Rejects Orexigen’s Weight-Loss Drug, Arena Lays Off 66, ResMed CEO Jumps to CareFusion, & More San Diego Life Sciences News	Bruce V. Bigelow	02/03/11	San Diego
The World’s Most Innovative City	Tim Rowe	02/02/11	Boston
Vertex Urges CDC to Recommend Hep C Screening, To Nudge “Second Tsunami” of Patients	Luke Timmerman	02/02/11	Boston
Heartland, Vertex Moving to Boston’s Waterfront	Gregory T. Huang	01/27/11	Boston
Seattle Genetics Manager Accused of Insider Trading, Bristol Stays in Seattle, Amgen Buys BioVex, & More Seattle-Area Life Sciences News	Luke Timmerman	01/27/11	Seattle
How ZymoGenetics Coulda Been a Contender: The Big Break That Came Too Late	Luke Timmerman	01/25/11	Seattle
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News	Erin Kutz	01/21/11	Boston
Vertex Granted Speedy FDA Review	Luke Timmerman	01/20/11	Boston
Roche Ends Deal with Ligand	Bruce V. Bigelow	11/24/10	San Diego
Page 2 of 7	« previous page · next page »

Entry

Author

Date

Location

Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug

Luke Timmerman

05/23/11

Boston

Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry

Luke Timmerman

05/17/11

New York